Clinical trial on a new combination of hepatoprotecting agents
Barlattani, M.
Arzneimittel-Forschung 20(4): 560-565
1970
ISSN/ISBN: 0004-4172 PMID: 4192590 Document Number: 30368
Document emailed within 1 workday
Related Documents
Sonoo, H.; Senoo, T.; Nishiki, M.; Morimoto, T.; Takashima, S. 1996: Effectiveness of combination hormonal therapies in advanced or recurrent breast cancer--a randomized trial of tamoxifen (TAM), medroxyprogesterone acetate (MPA), their simultaneous combination, and an alternating sequential combination of TAM plus MPA Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(4): 447-454Dave, B.T.; Munsi, C.P.; Bhakta, R.D.; Parikh, H.M.; Gulati, O.D. 1970: A clinical trial of guanoxan alone and in combination with polythiazide in hypertension Indian Heart Journal 22(2): 83-94
Ti, T.K.; Yong, N.K. 1974: Combination cancer chemotherapy--a clinical trial on outpatients Medical Journal of Malaysia 28(3): 165-170
Fukuo, Y.; Terashi, A.; Hayashi, Y.; Yano, Y.; Atarashi, J. 1985: A clinical trial of cis-platinum (II) in combination with PSK and FT-207 in advanced stomach cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(4): 960-965
Audebert, A.; Emperaire, J.C.; Gauthier, A.; Hallonet, P.; Hedon, B.; Lopes, P.; Quereux, C.; Roulier, R. 1991: Multicentric clinical trial of a combination of 35 micrograms of ethinylestradiol and 2 mg of cyproterone acetate Revue Francaise de Gynecologie et d'Obstetrique 86(11): 697-699
Chenebault, J. 1971: Clinical trial of a new chemotherapeutic combination designated Ro 6-2580 in bronchopneumopathy in adults Maroc Medical 51(549): 514-516
Van der Merwe, A.M.; Falkson, G.; Sandison, A.G.; van Dyk, J.J.; Falkson, H.C. 1973: Advanced lung cancer: a clinical trial of radiotherapy plus two drug combination regimens South African Medical Journal 47(46): 2219-2222
Di Veroli, C.; Petrucci, D.; Romeo, B. 1977: Double-blind clinical trial of a new pyridazine and its combination with reserpine in hypertensive patients La Clinica Terapeutica 82(6): 551-567
Etzel, M.; Lehmann, H.; Steiner, H.; Wesenberg, W. 1976: Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Fourth communication: Clinical results with CN 3123 in infections of the gastrointestinal tract, the skin and gynecological adnexes Arzneimittel-Forschung 26(42): 674-676
Spinner, D.; Walter, J.; Vazquez-Gragg, M.; Bloise, T.; Stafford-Smith, M.; Faulkner, E.; Taekman, J. 2011: Php74 Clinical Trial Learning Curves Affect Outcomes Measurement, Patient Safety and Trial Success: Contributing Factors and a Potential Solution in Clinical Trial Simulation Value in Health 14(3): A24-A25
Peters, H.J.; Nuri, M.; Popa, G. 1977: Antibacterial therapy of urinary tract infections. Results of a clinical trial with the combination sulfamoxol/Trimethoprim (= CN 3123) Münchener Medizinische Wochenschrift 119(12): 409-412
Wilairatana, P.; Krudsood, S.; Chokejindachai, W.; Bussaratid, V.; Silachamroon, U.; Viriyavejakul, P.; Hendriksen, C.; Scheiwe, M.W.; Looareesuwan, S. 1998: A clinical trial of combination of artesunate and mefloquine in the treatment of acute uncomplicated falciparum malaria: a short and practical regimen Southeast Asian Journal of Tropical Medicine and Public Health 29(4): 696-701
Rolandi, E.; Cicchetti, V.; Longinotti, M. 1972: Controlled clinical trial (with a sequential method) of a combination of metoclopramide and an enzymatic choleretico-tensio-active complex in dyspeptic syndromes La Clinica Terapeutica 60(6): 535-560
Angelova, I. 1984: Clinical trial of the herbal combination Dietosan in the species and disperg forms for treating patients with non-insulin-dependent diabetes mellitus Vutreshni Bolesti 23(6): 52-55
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285
Ricciardi, S.; Cerqua, R. 1977: Controlled double-blind trial on the clinical effects of the chenodeoxycholic acid-fentonium bromide combination in the symptomatic treatment of biliary spastic-dyskinetic conditions Arzneimittel-Forschung 27(6): 1226-1230
Etzel, M.; Wesenberg, W. 1976: Clinical trial of the antibacterial combination sulfamoxole/trimethoprim (CN 3123)/Sixth communication: Results of compatibility of CN 3123 Arzneimittel-Forschung 26(42): 678-683
Benson, C.A.; Williams, P.L.; Cohn, D.L.; Becker, S.; Hojczyk, P.; Nevin, T.; Korvick, J.A.; Heifets, L.; Child, C.C.; Lederman, M.M.; Reichman, R.C.; Powderly, W.G.; Notario, G.F.; Wynne, B.A.; Hafner, R. 2000: Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team Journal of Infectious Diseases 181(4): 1289-1297
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Koetsawang, S.; Ji, G.; Krishna, U.; Cuadros, A.; Dhall, G.I.; Wyss, R.; Rodriquez la Puenta, J.; Andrade, A.T.; Khan, T.; Kononova, E.S. 1990: Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Contraception 41(2): 125-141